Source: BioPortfolio

Hengrui Therapeutics: Week in Review Hengrui's US Spinoff Funded with $100 Million

Hengrui Therapeutics a New Jersey offshoot of Jiangsu Hengrui Medicine raised $100 million in initial funding from Jiangsu Hengrui and an unnamed investment firm; Spring Rain Software of Beijing raised $183 million in a preIPO round for its mobile healthca...

Read full article »

Top Competitors or Alternatives

Looks like nobody has added any competitors for Hengrui Therapeutics yet.

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Adam Zong's photo - President & CEO of Hengrui Therapeutics

President & CEO

Adam Zong

CEO Approval Rating


Read more